Literature DB >> 11433297

N-CAM modulates tumour-cell adhesion to matrix by inducing FGF-receptor signalling.

U Cavallaro1, J Niedermeyer, M Fuxa, G Christofori.   

Abstract

Loss of expression of neural cell-adhesion molecule (N-CAM) is implicated in the progression of tumour metastasis. Here we show that N-CAM modulates neurite outgrowth and matrix adhesion of beta-cells from pancreatic tumours by assembling a fibroblast-growth-factor receptor-4 (FGFR-4) signalling complex, which consists of N-cadherin, FGFR-4, phospholipase C gamma (PLC-gamma), the adaptor protein FRS2, pp60(c-src), cortactin and growth-associated protein-43 (GAP-43). Dominant-negative FGFR-4, inhibitors of FGFR signalling and anti-beta(1)-integrin antibodies repress matrix adhesion induced by N-CAM. FGF ligands can replace N-CAM in promoting matrix adhesion but not neurite outgrowth. The results indicate that N-CAM stimulates beta1-integrin-mediated cell-matrix adhesion by activating FGFR signalling. This is a potential mechanism for preventing the dissemination of metastatic tumour cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11433297     DOI: 10.1038/35083041

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  98 in total

1.  CD44 is required for two consecutive steps in HGF/c-Met signaling.

Authors:  Véronique Orian-Rousseau; Linfeng Chen; Jonathan P Sleeman; Peter Herrlich; Helmut Ponta
Journal:  Genes Dev       Date:  2002-12-01       Impact factor: 11.361

2.  Activation of EGF receptor kinase by L1-mediated homophilic cell interactions.

Authors:  Rafique Islam; Lars V Kristiansen; Susana Romani; Luis Garcia-Alonso; Michael Hortsch
Journal:  Mol Biol Cell       Date:  2004-01-12       Impact factor: 4.138

3.  Neuronal differentiation and protection from nitric oxide-induced apoptosis require c-Jun-dependent expression of NCAM140.

Authors:  Zhiwei Feng; Lei Li; Poh Yong Ng; Alan G Porter
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

Review 4.  Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis.

Authors:  Christopher Lieu; John Heymach; Michael Overman; Hai Tran; Scott Kopetz
Journal:  Clin Cancer Res       Date:  2011-09-27       Impact factor: 12.531

5.  Fibronectin-mediated adhesion rescues cell cycle arrest induced by fibroblast growth factor-1 by decreased expression of p21(cip/waf) in human chondrocytes.

Authors:  Jun-Hyeog Jang; Chong-Pyoung Chung
Journal:  In Vitro Cell Dev Biol Anim       Date:  2005 May-Jun       Impact factor: 2.416

6.  APC/C(Fzr/Cdh1)-dependent regulation of cell adhesion controls glial migration in the Drosophila PNS.

Authors:  Marion Silies; Christian Klämbt
Journal:  Nat Neurosci       Date:  2010-10-03       Impact factor: 24.884

7.  NCAM and FGFR1 coexpression and colocalization in renal tumors.

Authors:  Sanja Ćirović; Jelena Vještica; Claudia A Mueller; Svetislav Tatić; Jovan Vasiljević; Sanja Milenković; Gerhard A Mueller; Jasmina Marković-Lipkovski
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

8.  The role of mediators of cell invasiveness, motility, and migration in the pathogenesis of silent corticotroph adenomas.

Authors:  Ozgur Mete; Caroline Hayhurst; Hussein Alahmadi; Eric Monsalves; Hasan Gucer; Fred Gentili; Shereen Ezzat; Sylvia L Asa; Gelareh Zadeh
Journal:  Endocr Pathol       Date:  2013-12       Impact factor: 3.943

9.  PX-RICS mediates ER-to-Golgi transport of the N-cadherin/beta-catenin complex.

Authors:  Tsutomu Nakamura; Tomoatsu Hayashi; Yukiko Nasu-Nishimura; Fumika Sakaue; Yasuyuki Morishita; Toshio Okabe; Susumu Ohwada; Ken Matsuura; Tetsu Akiyama
Journal:  Genes Dev       Date:  2008-05-01       Impact factor: 11.361

10.  Human cytomegalovirus infection of tumor cells downregulates NCAM (CD56): a novel mechanism for virus-induced tumor invasiveness.

Authors:  Roman A Blaheta; Wolf-Dietrich Beecken; Tobias Engl; Dietger Jonas; Elsie Oppermann; Michael Hundemer; Hans Wilhelm Doerr; Martin Scholz; Jindrich Cinatl
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.